Literature DB >> 7317889

Nine years' follow-up of a maximal exercise test in a random population sample of middle-aged men.

L Wilhelmsen, J Bjure, B Ekström-Jodal, M Aurell, G Grimby, K Svärdsudd, G Tibblin, H Wedel.   

Abstract

A stepwise bicycle exercise test up to maximum was performed in a random population sample of 793 Swedish men, all aged 54 years. High respiratory rate during exercise characterized those who later suffered myocardial infarction (MI) or sudden coronary death (SD). In addition to high cholesterol, high blood pressure (BP), and smoking, low maximal performance, but not ST changes during exercise, increased the risk of MI + SD also in multivariate analysis. Pulse rate, systolic BP at both submaximal and maximal work load were positively correlated with the initial blood pressure level. BP at these work loads was also positively correlated with subsequent BP increase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7317889

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

1.  Physical activity and coronary heart disease.

Authors:  G David Batty; I-Min Lee
Journal:  BMJ       Date:  2004-05-08

Review 2.  The HERITAGE Family Study: A Review of the Effects of Exercise Training on Cardiometabolic Health, with Insights into Molecular Transducers.

Authors:  Mark A Sarzynski; Treva K Rice; Jean-Pierre Després; Louis Pérusse; Angelo Tremblay; Philip R Stanforth; André Tchernof; Jacob L Barber; Francesco Falciani; Clary Clish; Jeremy M Robbins; Sujoy Ghosh; Robert E Gerszten; Arthur S Leon; James S Skinner; D C Rao; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2022-05-01

Review 3.  Exercise in coronary heart disease.

Authors:  R J Shephard
Journal:  Sports Med       Date:  1986 Jan-Feb       Impact factor: 11.136

4.  Exercise in leisure time: coronary attack and death rates.

Authors:  J N Morris; D G Clayton; M G Everitt; A M Semmence; E H Burgess
Journal:  Br Heart J       Date:  1990-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.